Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-16
1991-01-15
Chaudhuri, Olik
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3146
Patent
active
049854372
ABSTRACT:
The invention relates to the use of certain compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT.sub.3 receptors for the treatment of cognitive disorders such as attentional and memory deficits and dementia states.
REFERENCES:
patent: 4624961 (1986-11-01), Welstead, Jr.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4789673 (1988-12-01), Donatsch et al.
patent: 4803199 (1989-02-01), Donatsch et al.
patent: 4826838 (1989-05-01), Richardson et al.
patent: 4851407 (1989-07-01), Wootton et al.
Altman et al., Psychopharmacology, 90, 24-27 (1986).
Essman, Advances in Biochemical Psychopharmacology, 11, 265-274 (1974).
Chaudhuri Olik
Glaxo Group Limited
Johnson Jerry D.
LandOfFree
Medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55498